✨ Free AI Report
Divi's Laboratories Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Divi's Laboratories Limited
Research Preview

Divi's Laboratories Limited: Business Overview, Financials & Competitive Analysis

Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. The company is a leading pharmaceut...

Analyst-debate audio for Divi's Laboratories Limited

AskCyborg analysts argue the bull and bear cases for Divi's Laboratories Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Divi's Laboratories Limited OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
7/ 10Strong

Cyborg Score thesis

Leading API manufacturer with diversified exposure to generic and custom synthesis markets positioned for medium-term growth...

Read the full analyst-debate transcript →
Industry Pharmaceutical Manufacturing (Active Pharmaceutical Ingredients & Contract Manufacturing)
4 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest Divi's Laboratories Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Divi's Laboratories Limited Overview

Pro stress-test →

Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. The company is a leading pharmaceutical company with custom synthesis business driving growth amid ongoing pricing pressures in the generics segment. Divi's manufactures Generic APIs, Intermediates, and Nutraceutical Ingredients, and offers Custom Synthesis of APIs to Big Pharma, providing a competitive advantage throughout the entire product lifecycle.

Strategic Profile

Pro stress-test →

The company manufactures 30 Large Volume Generic APIs and offers Custom Synthesis of APIs and Intermediates for global companies with a portfolio of products across diverse therapeutic areas. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world. Divis Laboratories' strong performance in custom synthesis business demonstrates the company's resilience and strategic positioning in the pharmaceutical industry, while continuing to invest in future growth opportunities, particularly in custom synthesis and peptide development.

Competitive Landscape

Pro stress-test →

Zydus Lifesciences, Wockhardt, Syngene International, Evotec, and Intas Pharmaceuticals are among the competitors of Divi's Laboratories. Major competitors include Laurus Labs, Neuland Laboratories, Acutaas Chemicals, Granules India, Alivus Life Sciences, Aarti Pharmalabs, and Shilpa Medicare. Divis maintains competitive advantage through scale, geographic diversification, and dual focus on generic and custom synthesis segments.

Industry Context

Divi's Laboratories Limited operates in Pharmaceutical Manufacturing (Active Pharmaceutical Ingredients & Contract Manufacturing).

Key facts

Founded: 1990 · Headquarters: Hyderabad, India · Employees: 10000+ · Revenue: $1.16B · Market cap: $18.9B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Divi's Laboratories Limited.

+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Divi's Laboratories Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Syngene InternationalContract research and manufacturing services→Laurus LabsAPI and specialty pharmaceutical manufacturer→Zydus LifesciencesIntegrated pharmaceutical company→Granules IndiaFormulation and API manufacturer→

Compare Divi's Laboratories Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Divi's Laboratories Limited operates in Pharmaceutical Manufacturing (Active Pharmaceutical Ingredients & Contract Manufacturing). See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Manufacturing (Active Pharmaceutical Ingredients & Contract Manufacturing) research →
NEW · MCP server

Ask your AI assistant about Divi's Laboratories Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Divi's Laboratories Limited and its top competitor on Cyborg Score”
“What did Divi's Laboratories Limited do this quarter?”
“Is Divi's Laboratories Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Divi's Laboratories Limited do?+
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. The company is a leading pharmaceut...
What is Divi's Laboratories Limited's Cyborg Score?+
Divi's Laboratories Limited has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Divi's Laboratories Limited's main competitors?+
Named competitors include Syngene International, Laurus Labs, Zydus Lifesciences, Granules India. The full competitive landscape is in the AskCyborg report.
How can I get the full Divi's Laboratories Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Divi's Laboratories Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Divi's Laboratories Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.